scispace - formally typeset
Open AccessJournal ArticleDOI

Immunology of COVID-19: Current State of the Science.

Nicolas Vabret, +87 more
- 16 Jun 2020 - 
- Vol. 52, Iss: 6, pp 910-941
Reads0
Chats0
TLDR
The current state of knowledge of innate and adaptive immune responses elicited by SARS-CoV-2 infection and the immunological pathways that likely contribute to disease severity and death are summarized.
About
This article is published in Immunity.The article was published on 2020-06-16 and is currently open access. It has received 1350 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Coronavirus biology and replication: implications for SARS-CoV-2.

TL;DR: The first discoveries that shape the current understanding of SARS-CoV-2 infection throughout the intracellular viral life cycle are summarized and relate that to the knowledge of coronavirus biology.
References
More filters
Journal ArticleDOI

Evolution and Global Transmission of a Multidrug-Resistant, Community-Associated Methicillin-Resistant Staphylococcus aureus Lineage from the Indian Subcontinent

Eike J. Steinig, +40 more
- 26 Nov 2019 - 
TL;DR: The Bengal Bay clone emerged from a virulent progenitor circulating on the Indian subcontinent and subsequently global transmission was associated with travel or family contact in the region, demonstrating the importance of whole-genome sequencing for tracking the evolution of emerging and resistant pathogens.
Journal ArticleDOI

Chloroquine: Modes of action of an undervalued drug

TL;DR: Chloroquine has recently been tested as adjunct therapy in several inflammatory situations, such as rheumatoid arthritis and transplantation procedures, presenting intriguing and promising results.
Journal ArticleDOI

MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis

TL;DR: The absence of all four Middle East respiratory syndrome CoV accessory ORFs has major implications for viral replication and pathogenesis and disruption of accessory ORF functions in parallel may offer a rapid response platform to attenuation of future emergent strains based on both SARS- and MERS-CoV accessory OrF mutants.
Posted ContentDOI

The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement

TL;DR: The data suggest that an RBD-based vaccine for SARS-CoV-2 could be safe and effective, and that anti-sera from immunized animals did not mediate antibody-dependent enhancement of S-protein-mediated entry under conditions in which Zika virus ADE was readily observed.
Related Papers (5)